EJP RD HIGHLIGHTS
The Research Training Workshop Call is now open until March 7th, 2021
The goal of the workshops is to train researchers and clinicians affiliated to ERN- Full Members or – Affiliated Partners in relevant topics on research in rare diseases. Training themes may include innovative research methodologies, diagnostic research methodologies, interdisciplinary treatment approaches, such as gene therapy and transplantation, etc. Moreover, the workshops will be aiming to provide a cross-ERN added value.
EURORDIS Rare2030 Final Conference and 10th annual Black Pearl Award
Looking for exciting new events? Don’t miss out and join EURORDIS LIVE at the Rare2030 Final Conference and the 10th annual Black Pearl Award.
EJP RD Resource Webinars
As you know EJP RD is organising webinars to showcase the resources involved in the programme and address the following: (1) what is this resource, and how is it related to EJP RD ? (2) How can this resource be helpful for clinicians / researchers involved in rare disease studies? and (3) how can this resource be used by the audience?
Join the Coordination Team!
The Coordination Unit is hiring a Junior Project Manager and a Project Assistant
EMA has recommended granting a marketing authorisation in the European Union for the first treatment that can be given orally to patients with certain types of spinal muscular atrophy (SMA), a rare and often fatal genetic disease that causes muscle weakness and progressive loss of movement. Evrysdi is indicated for the treatment of 5q SMA Read more about EMA – First oral treatment for spinal muscular atrophy (SMA) recommended for approval[…]
Happy Rare Disease Day! Watch EJP RD contributors answer the web’s most search questions about rare diseases in a new video that you can find HERE (subtitles available). Like every year, EJP RD is proud to contribute to spreading awareness on Rare Disease Day. Don’t forget to share the video and subscribe to our Youtube channel and to our Twitter to be kept updated on our funding opportunities, Read more about The EJP RD Rare Disease Day Video is online![…]
(Pre-proposal deadline: 31 March 2021) Angelini Pharma is an international group, leader in health care and well-being, committed to help patients, doctors and caregivers in the fight against diseases with constant and prevalent attention in the areas of Pain and Inflammation and Mental Health. Angelini Pharma has made research its core business to improve patients’ Read more about ANGELINI FOR FUTURE 2021 – Supports for Independent Research in Rare Diseases – Call for Proposals[…]
1- 2 March 2021 ONLINE The 1st International Conference on Rare Diseases “Building a Pathway from Diagnosis to Access” recognises that the next decade holds great potential for improvement and that while we cannot predict the future, we all have a role in preparing for it. As the EU shapes its future regulations, strategies and Read more about 1st International Conference on Rare Diseases “Building a Pathway from Diagnosis to Access”[…]
March 10-12, 2021- online event Neuroacanthocytosis syndromes (NA) are a group of rare, but devastating, neurodegenerative disorders, with Chorea Acanthocytosis as the “core” disease of this family. To date there are no treatments that can halt or slowdown the progression of these diseases. Since these are ultra-rare disease, there is very little or no support Read more about 10th International Meeting on Neuroacanthocytosis Syndromes – Networking event[…]
The virtual event Unlocking innovation and access for rare disease patients in Europe was held online on the 22nd of February. With over 700 registrations from across the European rare disease community, the event was full of insights on the impact that policy decisions have the quality of lives of people affected by rare diseases. Read more about Unlocking innovation and access for rare disease patients in Europe – Sessions recording available[…]
Heritable human genome editing has been proposed as a means of helping parents avoid passing genetic diseases to future generations. But can heritable human genome editing be used safely? On February 26, 2021 at 9:00 am EST (2 pm GMT / 3pm CET / 10 pm CST), join members of the International Commission on the Read more about Heritable Human Genome Editing Rare Disease Week Discussion[…]
The International Rare Diseases Research Consortium (IRDiRC) is glad to announce the opening of two new Task Forces: “Shared Molecular Etiologies Underlying Multiple Rare Diseases” aiming to address and document the existing challenges in adapting the basket trial approach used in molecularly targeted oncology clinical trials to drugs targeting shared molecular etiologies underlying multiple rare Read more about IRDiRC: Two New Task Forces[…]
Biogen’s virtual event: virtual event: “Unlocking innovation and access for rare disease patients in Europe”
On the occasion of Rare Disease Day 2021, Biogen is pleased to invite you to the virtual event: “Unlocking innovation and access for rare disease patients in Europe” taking place on Monday, 22 February from 14:00 to 15:45 CET. Biogen’s event, done in collaboration with Reuters and EU40, will highlight the need for continued political Read more about Biogen’s virtual event: virtual event: “Unlocking innovation and access for rare disease patients in Europe”[…]
Ring14 International yearly solicits international research projects focused on the Ring 14 or chromosome 14 related syndromes. The projects can be basic or pre-clinical, the ultimate goal is to find a cure for these conditions. The Board of Directors of Ring 14 International, is pleased to inform that the 2021 call for applications has been issued Read more about RING 14 – Call For Research Grant Application 2021[…]